- Home
- NXTT vs INM Comparison
NXTT vs INM Comparison
Compare NXTT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- INM
- Stock Information
- Founded
- NXTT 2019
- INM 1981
- Country
- NXTT China
- INM Canada
- Employees
- NXTT N/A
- INM N/A
- Industry
- NXTT
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- NXTT
- INM Health Care
- Exchange
- NXTT NYSE
- INM Nasdaq
- Market Cap
- NXTT 3.5M
- INM 3.2M
- IPO Year
- NXTT N/A
- INM N/A
- Fundamental
- Price
- NXTT $0.30
- INM $3.00
- Analyst Decision
- NXTT
- INM
- Analyst Count
- NXTT 0
- INM 0
- Target Price
- NXTT N/A
- INM N/A
- AVG Volume (30 Days)
- NXTT 74.8K
- INM 56.6K
- Earning Date
- NXTT 05-19-2025
- INM 05-13-2025
- Dividend Yield
- NXTT N/A
- INM N/A
- EPS Growth
- NXTT N/A
- INM N/A
- EPS
- NXTT 3.73
- INM N/A
- Revenue
- NXTT $1,800,000.00
- INM $4,832,013.00
- Revenue This Year
- NXTT N/A
- INM N/A
- Revenue Next Year
- NXTT N/A
- INM N/A
- P/E Ratio
- NXTT $0.08
- INM N/A
- Revenue Growth
- NXTT N/A
- INM N/A
- 52 Week Low
- NXTT $0.22
- INM $1.72
- 52 Week High
- NXTT $6.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- NXTT 40.27
- INM 62.76
- Support Level
- NXTT $0.25
- INM $2.56
- Resistance Level
- NXTT $0.32
- INM $3.05
- Average True Range (ATR)
- NXTT 0.03
- INM 0.27
- MACD
- NXTT 0.03
- INM 0.09
- Stochastic Oscillator
- NXTT 80.00
- INM 92.98
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.